This inventor holds 1 USPTO granted patent. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Imke Grune: Innovator in Pharmaceutical Composition
Introduction
Imke Grune is a notable inventor based in Koblenz, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating autoimmune and tumoral diseases.
Latest Patents
Imke Grune holds a patent for "Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors." This invention relates to a pharmaceutical composition that includes compounds selected from specific general formulas and their enantiomers, diastereomers, or pharmaceutically acceptable salts. The composition is designed for use in treating autoimmune and tumoral diseases, as well as for immunosuppression.
Career Highlights
Imke Grune is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where she has been involved in groundbreaking research. Her work has led to advancements in the understanding and treatment of complex medical conditions.
Collaborations
Imke has collaborated with esteemed colleagues, including Michael Famulok and Barbara Tappertzhofen, who have contributed to her research endeavors.
Conclusion
Imke Grune's innovative work in pharmaceutical compositions highlights her commitment to advancing medical science. Her contributions are paving the way for new treatments in the field of immunology and oncology.